Form 4: SOPHiA GENETICS Officer Sells Shares

SOPHiA GENETICS SA Chief Medical Officer, Philippe Menu, reported transactions involving the sale of ordinary shares, executed under a Rule 10b5-1(c) trading plan.

Summary

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, reported the sale of 3,725 ordinary shares on April 10, 2026, for a weighted average price of $4.6822.
• Additional sales of 1,000 ordinary shares and 3,400 ordinary shares were reported on April 13, 2026, at weighted average prices of $4.7642.
• These transactions were conducted under a pre-established Rule 10b5-1(c) trading plan to satisfy tax withholding obligations related to vested restricted stock units.
• Following these transactions, Philippe Menu beneficially owns 268,596 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as the reported share sales by an executive are attributed to a pre-arranged trading plan for tax purposes, rather than a discretionary decision to divest.

Negatives

• Sale of a significant number of shares by a key executive, although conducted under a pre-planned trading strategy.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider sales, even when executed under a Rule 10b5-1 plan, can sometimes be interpreted by the market as a signal of reduced confidence by management, though in this case, the stated purpose is tax withholding, which is a common and often necessary reason for such sales.

Stakeholder Impact

• Shareholders: May perceive insider selling, even if planned, as a potential negative signal, though the tax withholding reason mitigates this concern.
• Employees: The transaction relates to executive compensation and tax obligations, with no direct impact on other employees.
• Creditors: No direct impact on creditors.
• Suppliers: No direct impact on suppliers.

Key Dates

Keywords

SOPHiA GENETICS SA, Form 4, Insider Trading, Share Sale, Rule 10b5-1, Chief Medical Officer, Stock Options, Restricted Stock Units, Tax Withholding